JP7470453B2 - 動物データを監視用に収集および配信するための、無人航空機(uav)ベースのシステム - Google Patents
動物データを監視用に収集および配信するための、無人航空機(uav)ベースのシステム Download PDFInfo
- Publication number
- JP7470453B2 JP7470453B2 JP2022502866A JP2022502866A JP7470453B2 JP 7470453 B2 JP7470453 B2 JP 7470453B2 JP 2022502866 A JP2022502866 A JP 2022502866A JP 2022502866 A JP2022502866 A JP 2022502866A JP 7470453 B2 JP7470453 B2 JP 7470453B2
- Authority
- JP
- Japan
- Prior art keywords
- data
- unmanned aerial
- sensor
- sensors
- aerial vehicle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001465754 Metazoa Species 0.000 title claims description 261
- 238000012544 monitoring process Methods 0.000 title description 20
- 230000006854 communication Effects 0.000 claims description 169
- 238000004891 communication Methods 0.000 claims description 169
- 230000009471 action Effects 0.000 claims description 99
- 238000012545 processing Methods 0.000 claims description 29
- 230000005540 biological transmission Effects 0.000 claims description 28
- 230000000694 effects Effects 0.000 claims description 22
- 230000006870 function Effects 0.000 claims description 22
- 230000033001 locomotion Effects 0.000 claims description 19
- 238000013480 data collection Methods 0.000 claims description 16
- 238000009826 distribution Methods 0.000 claims description 15
- 230000036541 health Effects 0.000 claims description 14
- 230000008859 change Effects 0.000 claims description 13
- 210000004369 blood Anatomy 0.000 claims description 11
- 239000008280 blood Substances 0.000 claims description 11
- 210000004243 sweat Anatomy 0.000 claims description 10
- 230000007613 environmental effect Effects 0.000 claims description 9
- 210000001124 body fluid Anatomy 0.000 claims description 8
- 230000004931 aggregating effect Effects 0.000 claims description 7
- 230000001815 facial effect Effects 0.000 claims description 7
- 230000002708 enhancing effect Effects 0.000 claims description 6
- 230000002068 genetic effect Effects 0.000 claims description 6
- 210000003205 muscle Anatomy 0.000 claims description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 239000008103 glucose Substances 0.000 claims description 5
- 230000002194 synthesizing effect Effects 0.000 claims description 5
- 230000036772 blood pressure Effects 0.000 claims description 4
- 239000010839 body fluid Substances 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 4
- 230000001133 acceleration Effects 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 230000017531 blood circulation Effects 0.000 claims description 3
- 230000008451 emotion Effects 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 208000032370 Secondary transmission Diseases 0.000 claims description 2
- 230000036757 core body temperature Effects 0.000 claims description 2
- 239000011591 potassium Substances 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 230000036387 respiratory rate Effects 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 230000007175 bidirectional communication Effects 0.000 claims 1
- 238000004159 blood analysis Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 description 81
- 238000004088 simulation Methods 0.000 description 46
- 238000013473 artificial intelligence Methods 0.000 description 35
- 230000001276 controlling effect Effects 0.000 description 24
- 238000004364 calculation method Methods 0.000 description 21
- 239000000306 component Substances 0.000 description 20
- 238000005259 measurement Methods 0.000 description 18
- 238000004458 analytical method Methods 0.000 description 17
- 230000006872 improvement Effects 0.000 description 17
- 230000003287 optical effect Effects 0.000 description 17
- 230000004044 response Effects 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 15
- 238000005755 formation reaction Methods 0.000 description 15
- 230000008569 process Effects 0.000 description 15
- 230000008827 biological function Effects 0.000 description 14
- 230000001976 improved effect Effects 0.000 description 13
- 238000013528 artificial neural network Methods 0.000 description 12
- 230000000007 visual effect Effects 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 238000010801 machine learning Methods 0.000 description 10
- 241000282412 Homo Species 0.000 description 9
- 230000001413 cellular effect Effects 0.000 description 8
- 230000029058 respiratory gaseous exchange Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000012546 transfer Methods 0.000 description 7
- 238000004422 calculation algorithm Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 230000001131 transforming effect Effects 0.000 description 6
- 230000036760 body temperature Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 101150049278 US20 gene Proteins 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000005265 energy consumption Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 210000003296 saliva Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000283086 Equidae Species 0.000 description 3
- 206010019280 Heart failures Diseases 0.000 description 3
- QVFWZNCVPCJQOP-UHFFFAOYSA-N chloralodol Chemical compound CC(O)(C)CC(C)OC(O)C(Cl)(Cl)Cl QVFWZNCVPCJQOP-UHFFFAOYSA-N 0.000 description 3
- 238000013135 deep learning Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000037230 mobility Effects 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 238000001303 quality assessment method Methods 0.000 description 3
- 238000013179 statistical model Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000557626 Corvus corax Species 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000288906 Primates Species 0.000 description 2
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 2
- 102000007066 Prostate-Specific Antigen Human genes 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004820 blood count Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000007177 brain activity Effects 0.000 description 2
- 239000008358 core component Substances 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000009795 derivation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000004134 energy conservation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000013213 extrapolation Methods 0.000 description 2
- 230000010006 flight Effects 0.000 description 2
- 229940014144 folate Drugs 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000005021 gait Effects 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000718 qrs complex Methods 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 238000000528 statistical test Methods 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000001755 vocal effect Effects 0.000 description 2
- RBSXHDIPCIWOMG-UHFFFAOYSA-N 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea Chemical compound CCS(=O)(=O)C=1N=C2C=CC=CN2C=1S(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 RBSXHDIPCIWOMG-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHOSNRCGJFBJIB-UHFFFAOYSA-N Candesartan cilexetil Chemical compound C=12N(CC=3C=CC(=CC=3)C=3C(=CC=CC=3)C3=NNN=N3)C(OCC)=NC2=CC=CC=1C(=O)OC(C)OC(=O)OC1CCCCC1 GHOSNRCGJFBJIB-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102400000921 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010027525 Microalbuminuria Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 102100030569 Nuclear receptor corepressor 2 Human genes 0.000 description 1
- 101710153660 Nuclear receptor corepressor 2 Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 210000003423 ankle Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011985 exploratory data analysis Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 238000009408 flooring Methods 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229940099472 immunoglobulin a Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003434 inspiratory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003155 kinesthetic effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000013450 outlier detection Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000013349 risk mitigation Methods 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000004984 smart glass Substances 0.000 description 1
- 238000012421 spiking Methods 0.000 description 1
- 238000013125 spirometry Methods 0.000 description 1
- 238000000547 structure data Methods 0.000 description 1
- 238000012706 support-vector machine Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
- A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K29/00—Other apparatus for animal husbandry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B5/02055—Simultaneously evaluating both cardiovascular condition and temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02438—Detecting, measuring or recording pulse rate or heart rate with portable devices, e.g. worn by the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/11—Measuring movement of the entire body or parts thereof, e.g. head or hand tremor, mobility of a limb
- A61B5/1112—Global tracking of patients, e.g. by using GPS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/117—Identification of persons
- A61B5/1171—Identification of persons based on the shapes or appearances of their bodies or parts thereof
- A61B5/1176—Recognition of faces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/42—Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
- A61B5/4261—Evaluating exocrine secretion production
- A61B5/4266—Evaluating exocrine secretion production sweat secretion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
- A61B5/4504—Bones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
- A61B5/4519—Muscles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4869—Determining body composition
- A61B5/4875—Hydration status, fluid retention of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6802—Sensor mounted on worn items
- A61B5/6804—Garments; Clothes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6861—Capsules, e.g. for swallowing or implanting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/74—Details of notification to user or communication with user or patient ; user input means
- A61B5/7465—Arrangements for interactive communication between patient and care services, e.g. by using a telephone network
- A61B5/747—Arrangements for interactive communication between patient and care services, e.g. by using a telephone network in case of emergency, i.e. alerting emergency services
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2503/00—Evaluating a particular growth phase or type of persons or animals
- A61B2503/12—Healthy persons not otherwise provided for, e.g. subjects of a marketing survey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2503/00—Evaluating a particular growth phase or type of persons or animals
- A61B2503/40—Animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0242—Operational features adapted to measure environmental factors, e.g. temperature, pollution
- A61B2560/0247—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value
- A61B2560/0252—Operational features adapted to measure environmental factors, e.g. temperature, pollution for compensation or correction of the measured physiological value using ambient temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0204—Acoustic sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/029—Humidity sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B3/00—Apparatus for testing the eyes; Instruments for examining the eyes
- A61B3/10—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
- A61B3/113—Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for determining or recording eye movement
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B64—AIRCRAFT; AVIATION; COSMONAUTICS
- B64U—UNMANNED AERIAL VEHICLES [UAV]; EQUIPMENT THEREFOR
- B64U2101/00—UAVs specially adapted for particular uses or applications
- B64U2101/20—UAVs specially adapted for particular uses or applications for use as communications relays, e.g. high-altitude platforms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Environmental Sciences (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Computer Networks & Wireless Communication (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Pulmonology (AREA)
- Business, Economics & Management (AREA)
- General Business, Economics & Management (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Optics & Photonics (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Artificial Intelligence (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Mathematical Physics (AREA)
- Nursing (AREA)
- Emergency Management (AREA)
- Critical Care (AREA)
- Signal Processing (AREA)
Description
Claims (38)
- 電子的に送信可能な動物データのソースであって、少なくとも1つのセンサを含み、動物データが少なくとも1つのターゲット個体から収集される、動物データのソースと、
前記動物データのソースから、前記動物データを受信される動物データの第1のセットとして受信する無人航空機であって、前記動物データのソースから1つまたは複数の信号を受信して、1つまたは複数の制御信号を前記動物データのソースに送るように動作可能な送受信機を有する、無人航空機と、
前記受信される動物データの第1のセットの少なくとも一部を受信するように動作可能なコンピューティングデバイスと、
ホームステーションと、を備え、
前記ホームステーションまたは前記コンピューティングデバイスが、ターゲット個体の第1のリストおよび第2のリストを示すように構成された制御用アプリケーションを実行し、前記第1のリストは、ユーザが監視する1以上の個体を選択できるように選択可能なものであり、前記第2のリストから、ユーザは選択されたターゲット個体に関連付けられた少なくとも1つのセンサを選択することができ、前記制御用アプリケーションは、さらに、ユーザが、どの選択された1つまたは複数のセンサを操作するかを識別することを可能にすることを特徴とする、無人航空機ベースのデータ収集および配信システム。 - 前記コンピューティングデバイス、中間サーバ、またはサードパーティに送信する前に、前記無人航空機が前記動物データを分析する、請求項1に記載のシステム。
- 前記ホームステーション、中間サーバ、またはサードパーティに送信する前に、前記無人航空機がメタデータを前記動物データに付加する、請求項1に記載のシステム。
- 前記メタデータが、前記動物データの特性、前記動物データの発信源、またはセンサデータを含む、請求項3に記載のシステム。
- 1つ以上の属性が、(1)前記動物データが発信された個体に関する、(2)前記センサに関する、または(3)前記動物データが収集された後で、前記メタデータに付加することができる、または前記動物データに関連付けられる動物データに関する、請求項3に記載のシステム。
- 前記無人航空機が少なくとも1つの前記センサと通信できない場合に、次のパラメータであって、時間、少なくとも1つの前記センサの場所、1以上の個体の場所、および1以上の無人航空機の場所、のうちの1つ以上のパラメータの変更の後で、前記無人航空機が少なくとも1つの前記センサと自動的に再接続されるようにプログラムされている、請求項1に記載のシステム。
- 少なくとも1つの前記センサと前記ホームステーションとの間の1以上の通信が、ネットワーク内において、非無人航空機の送信システムから1以上の無人航空機へと、またはその逆で移譲される、請求項1に記載のシステム。
- 前記ホームステーション、少なくとも1つのセンサ、および1以上の無人航空機を含むネットワークが、少なくとも1つの前記センサ、センサ信号、および/または収集した動物データに関する1以上の特性を監視する能力を提供する、請求項1に記載のシステム。
- 以下の特性であって、無人航空機の場所、無人航空機のペイロード、無人航空機の帯域幅、個体の場所、センサの場所、バッテリ寿命、信号強度、環境条件、および信号品質のうちの1以上の特性に基づいて、前記ホームステーションが、1以上の無人航空機を自動的に選択して少なくとも1つの前記センサと接続するようにプログラムされている、請求項1に記載のシステム。
- 前記ホームステーションまたはUAVが、(1)少なくとも1つの前記センサと1以上の無人航空機との間の、1以上のデータ通信ポイントにわたる信号品質および/または信号強度を検出および監視し、および(2)1以上のコマンドを前記センサに提供して、他の無人航空機または非無人航空機の送信システムである二次的な送信ソースとペアリングさせる、請求項1に記載のシステム。
- 1以上の無人航空機が、単一ネットワーク内において、複数のネットワーク内において、または互いに独立して機能し、1以上のホームステーションが1以上の無人航空機と通信し、2以上の無人航空機が互いに通信する、請求項1に記載のシステム。
- 1以上の無人航空機が他の装置に付属している、請求項1に記載のシステム。
- 前記コンピューティングデバイスが、前記ホームステーション、中間サーバ、または無人航空機である、請求項1に記載のシステム。
- 1以上の無人航空機が、付属した、取り付けられた、または埋め込まれた少なくとも1つのセンサを有し、当該センサは1以上のデータポイントをキャプチャし、前記無人航空機が(1)動物データをホームステーションおよび/またはサードパーティ、または中間サーバに中継する、または(2)キャプチャした動物データの少なくとも一部を使用して、キャプチャしたセンサの動物データを、洞察またはメトリクスに変換する、請求項1に記載のシステム。
- 前記無人航空機が、1つまたは複数の個体からの前記少なくとも1つのセンサと、1つまたは複数の無線通信プロトコルを使用して通信することができる、請求項1に記載のシステム。
- 前記ホームステーションが、1以上の無人航空機および/または少なくとも1つの前記センサを監視して、以下のイベントであって、(1)前記ホームステーション、中間サーバ、またはサードパーティにアラートする、および/または(2)前記ホームステーション、中間サーバ、またはサードパーティに予期される出力を送達するように、ホームステーションに少なくとも1つの補正的なアクションを行うように促す、イベントが発生する、請求項1に記載のシステム。
- 前記ホームステーション、少なくとも1つのセンサ、および1以上の無人航空機から構成されたネットワークが、センサ、ホームステーション、または無人航空機へと送信するまたはこれらから送信されたデータを不明瞭化する能力を提供する、請求項1に記載のシステム。
- 前記動物データが人間のデータである、請求項1に記載のシステム。
- 前記無人航空機および/または前記ホームステーションが1以上の分類を前記動物データに割り当てるように動作可能であり、1以上の前記分類が、メトリクス分類、洞察分類、データプロパティ、データ即時性分類、またはデータコンテキスト分類を含む、請求項1に記載のシステム。
- 少なくとも1つのセンサが、対象の身体、眼球または骨格系に取り付けられているか、接触しているか、または電気接続されているか、個体に埋め込まれているか、少なくとも1のターゲット個体内に持ち込まれているか、少なくとも1のターゲット個体により摂取されているか、または少なくとも1のターゲット個体と直接的にまたは1以上の中間物を介して接している繊維、生地、布、材料、器具、物体、または装置に、一部として一体化されているか、取り付けられているか、または埋め込まれている、請求項1に記載のシステム。
- 前記少なくとも1つのセンサが、1つまたは複数のターゲット個体から、生理学的データ、バイオメトリックデータ、化学的データ、生体力学的データ、場所データ、環境データ、遺伝子データ、ゲノムデータ、または他の生物学的データを集めるバイオセンサである、請求項20に記載のシステム。
- 前記少なくとも1つのセンサが、顔認識データ、アイトラッキング、バイオ信号、生体電気信号、血流、血液分析、血圧、体液、脈拍、酸素、深部体温、皮膚温度、発汗レベル、場所データ、位置座標、音声データ、生体力学的運動、血糖レベル、水分レベル、乳酸レベル、ナトリウムレベル、カリウムレベル、心拍、遺伝子情報、ゲノムデータ、骨格データ、筋肉活動、呼吸回数、様々な方向における位置または加速、周囲温度および湿度、大気圧、標高、のうちの少なくとも1つまたはこれらの組み合わせを収集する、請求項20に記載のシステム。
- 前記コンピューティングデバイスが、1つまたは複数のコマンドを前記無人航空機において実行する制御用アプリケーションを実行し、(1)収集した動物データの少なくとも一部を、リアルタイムまたはほぼリアルタイムで、制御用アプリケーション、中間サーバ、またはサードパーティのプラットフォームにストリーミングすること、(2)制御用アプリケーション、中間サーバ、またはサードパーティのシステムに送り返す1つ以上のデータストリームを選択すること、(3)データが制御用アプリケーション、中間サーバ、またはサードパーティのシステムに送り返される頻度を選択すること、(4)少なくとも1つのセンサから前記無人航空機において収集された動物データを、機械計算資産に変換し、1以上の機械計算資産を、制御用アプリケーション、中間サーバ、またはサードパーティのシステムに送信すること、(5)少なくとも1つのセンサから無人航空機への1以上のデータストリームを集約し、制御用アプリケーション、中間サーバ、またはサードパーティのシステムに送り返すことができる1以上の変換データを作成すること、(6)少なくとも1つの前記センサにおける1以上のセッティングを変更もしくは調節すること、(7)少なくとも1つの前記センサにアクションを実行するように命令することと、(8)無人航空機の位置を変更または調節すること、および(9)センサデータを保存すること、のうちの少なくとも1つまたはこれらの組み合わせを前記コマンドが開始する、請求項1に記載のシステム。
- 前記無人航空機が、少なくとも1つの前記センサと通信するデータ取得ユニットを含む、請求項1に記載のシステム。
- 前記データ取得ユニットが、二方向通信リンクを介してセンサと通信する送受信機モジュールを含み、前記二方向通信リンクにおいて、ユーザは、少なくとも1つの前記センサのための1以上のパラメータをアクティブ化して設定し、少なくとも1つの前記センサから1以上のデータを受信することができる、請求項24に記載のシステム。
- 前記送信機モジュールが、前記ホームステーション、サードパーティ、および/または中間サーバと通信するように動作可能である、請求項25に記載のシステム。
- 前記データ取得ユニットが、1以上のデータ処理ステップを実行するように動作可能なマイクロプロセッサを含む、請求項24に記載のシステム。
- 前記データ取得ユニットが、前記マイクロプロセッサと電子的に通信を行うメモリモジュールおよび入力/出力モジュールを含む、請求項27に記載のシステム。
- 1以上の処理ステップが、前記動物データを、正規化すること、タイムスタンプすること、集約すること、記憶すること、操作すること、増進すること、編成すること、分析すること、匿名化すること、要約すること、合成すること、帳簿付けすること、同期すること、および配信することを含むグループから選択される、請求項27に記載のシステム。
- 前記データ取得ユニットが通信モジュールを含む、請求項24に記載のシステム。
- 前記無人航空機は、顔認識ソフトウェアを利用するセンサが付属し、取り付けられ、または埋め込まれており、1以上のターゲットからの感情をキャプチャし、前記無人航空機は、収集したセンサデータを使用して、顔認識データを収集した動物データと相関させて、任意の時間における個体のストレスレベルを判定する、請求項1に記載のシステム。
- 少なくとも1つの前記センサが心拍の変動性を提供する、請求項1に記載のシステム。
- 前記制御用アプリケーションが前記コンピューティングデバイスにおいて実行され、スポーツイベントまたはスポーツ活動の間に、前記コンピューティングデバイスがサードパーティおよび/または中間サーバとリアルタイムまたはほぼリアルタイムで通信する、請求項1に記載のシステム。
- 前記無人航空機が、収集した動物データに基づいて健康状態または医療状態を検出し、アラートが発せられる、または収集した動物データの少なくとも一部が、前記無人航空機から、1以上のホームステーション、中間サーバ、またはサードパーティに送信される、請求項1に記載のシステム。
- 前記無人航空機は、人間を搭載せずに、遠隔制御または自律的な搭載型コンピュータにより操縦される航空機である、請求項1に記載のシステム。
- 1以上の無人航空機が、少なくとも1つのセンサまたは1以上の個体の位置に基づいて、当該無人航空機の位置または送受信機の配置を調節する、請求項1に記載のシステム。
- 1以上の無人航空機が、1以上のサードパーティと、中間サーバと、ホームステーションと、または互いと通信する、請求項1に記載のシステム。
- 1以上の無人航空機が、前記ホームステーションにより送信された1以上のコマンドに基づいて、同じデータセットの少なくとも一部に対して1以上の協調されたアクションを実行する、請求項1に記載のシステム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/517,012 | 2019-07-19 | ||
US16/517,012 US10980218B2 (en) | 2019-07-19 | 2019-07-19 | Unmanned aerial vehicle (UAV)-based system for collecting and distributing animal data for monitoring |
PCT/US2020/042705 WO2021016148A1 (en) | 2019-07-19 | 2020-07-20 | An unmanned aerial vehicle (uav)-based system for collecting and distributing animal data for monitoring |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2022541505A JP2022541505A (ja) | 2022-09-26 |
JPWO2021016148A5 JPWO2021016148A5 (ja) | 2023-07-31 |
JP7470453B2 true JP7470453B2 (ja) | 2024-04-18 |
Family
ID=74180838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022502866A Active JP7470453B2 (ja) | 2019-07-19 | 2020-07-20 | 動物データを監視用に収集および配信するための、無人航空機(uav)ベースのシステム |
Country Status (11)
Country | Link |
---|---|
US (3) | US10980218B2 (ja) |
EP (1) | EP3998937A4 (ja) |
JP (1) | JP7470453B2 (ja) |
KR (1) | KR20220047280A (ja) |
CN (1) | CN114828736A (ja) |
AU (1) | AU2020315882A1 (ja) |
BR (1) | BR112022001051A2 (ja) |
CA (1) | CA3144397A1 (ja) |
IL (1) | IL289913A (ja) |
MX (1) | MX2022000717A (ja) |
WO (1) | WO2021016148A1 (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11879705B2 (en) * | 2018-07-05 | 2024-01-23 | Mikael Bror Taveniku | System and method for active shooter defense |
US11850053B2 (en) | 2019-01-14 | 2023-12-26 | Sports Data Labs, Inc. | System for measuring heart rate |
US10980218B2 (en) * | 2019-07-19 | 2021-04-20 | Sports Data Labs, Inc. | Unmanned aerial vehicle (UAV)-based system for collecting and distributing animal data for monitoring |
US20230131370A1 (en) * | 2019-07-19 | 2023-04-27 | Sports Data Labs, Inc. | An unmanned aerial vehicle (uav)-based system for collecting and distributing animal data for monitoring |
US11514523B2 (en) * | 2019-10-28 | 2022-11-29 | Fmr Llc | AI-based real-time prediction engine apparatuses, methods and systems |
US11907335B2 (en) * | 2020-10-16 | 2024-02-20 | Cognitive Space | System and method for facilitating autonomous target selection |
US11798427B2 (en) * | 2021-01-25 | 2023-10-24 | The Boeing Company | Auto-labeling sensor data for machine learning |
US20230091659A1 (en) * | 2021-06-21 | 2023-03-23 | Mesos LLC | High-Altitude Airborne Remote Sensing |
CN114007148B (zh) * | 2021-10-21 | 2023-05-05 | 贵州师范学院 | 基于LoRa网关无人机群的水文监测系统 |
US11722462B1 (en) * | 2022-04-28 | 2023-08-08 | Beta Air, Llc | Systems and methods for encrypted flight plan communications |
CN115042907B (zh) * | 2022-06-27 | 2024-05-31 | 深圳哲轮科技有限公司 | 一种电动助力车的动力控制方法、系统及电动助力车 |
US11954753B2 (en) * | 2022-08-29 | 2024-04-09 | Bnsf Railway Company | Railroad operations image detection and identification system and method therefor |
CN116489193B (zh) * | 2023-05-04 | 2024-01-23 | 中国人民解放军陆军工程大学 | 一种作战网络自适应组合方法、装置、设备及介质 |
CN116319795B (zh) * | 2023-05-24 | 2023-08-01 | 无锡光煜晞科技有限责任公司 | 一种基于边缘计算的地铁列车无人驾驶探测识别系统 |
CN117250994B (zh) * | 2023-11-14 | 2024-02-02 | 贵州航天智慧农业有限公司 | 基于无人机追踪昆虫迁飞轨迹的方法及系统 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170202185A1 (en) | 2016-01-18 | 2017-07-20 | Dinklage Feed Yards, Inc. | Unmanned livestock monitoring system and methods of use |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10555498B2 (en) * | 2012-09-19 | 2020-02-11 | Botsitter, Llc | Method and system for remote monitoring, care and maintenance of animals |
US9643722B1 (en) | 2014-02-28 | 2017-05-09 | Lucas J. Myslinski | Drone device security system |
US9494936B2 (en) * | 2015-03-12 | 2016-11-15 | Alarm.Com Incorporated | Robotic assistance in security monitoring |
US10212922B2 (en) * | 2015-05-12 | 2019-02-26 | Sony Corporation | Management apparatus, individual management system, and individual search system |
AU2016268525A1 (en) * | 2015-05-25 | 2017-12-07 | Cattle-Watch Ltd | System and method for monitoring livestock |
EP3313731B1 (en) | 2015-06-24 | 2021-05-05 | Ent. Services Development Corporation LP | Control aerial movement of drone based on line-of-sight of humans using devices |
US20170193308A1 (en) | 2016-02-23 | 2017-07-06 | Clinimetrics S.A. | Systems and methods for personal security using autonomous drones |
US10204520B2 (en) | 2016-05-16 | 2019-02-12 | Orestis Demetriades | Unmanned aerial vehicle based security system |
US10537701B2 (en) * | 2016-07-05 | 2020-01-21 | International Business Machines Corporation | Alleviating movement disorder conditions using unmanned aerial vehicles |
US20180091875A1 (en) | 2016-09-28 | 2018-03-29 | International Business Machines Corporation | Monitoring the health and safety of personnel using unmanned aerial vehicles |
US11495118B2 (en) | 2017-06-27 | 2022-11-08 | Oneevent Technologies, Inc. | Augmented reality of a building |
US10555152B2 (en) | 2017-09-28 | 2020-02-04 | At&T Intellectual Property I, L.P. | Drone-to-drone information exchange |
US10489649B2 (en) | 2017-09-28 | 2019-11-26 | At&T Intellectual Property I, L.P. | Drone data locker system |
US11119222B2 (en) * | 2017-12-18 | 2021-09-14 | Korea Advanced Institute Of Science And Technology (Kaist) | Method and system for local-area differential GNSS for UAV navigation, and for generating optimal protection level and geometry screening therefor |
US10980218B2 (en) * | 2019-07-19 | 2021-04-20 | Sports Data Labs, Inc. | Unmanned aerial vehicle (UAV)-based system for collecting and distributing animal data for monitoring |
-
2019
- 2019-07-19 US US16/517,012 patent/US10980218B2/en active Active
-
2020
- 2020-07-20 CN CN202080065316.2A patent/CN114828736A/zh active Pending
- 2020-07-20 AU AU2020315882A patent/AU2020315882A1/en active Pending
- 2020-07-20 BR BR112022001051A patent/BR112022001051A2/pt unknown
- 2020-07-20 WO PCT/US2020/042705 patent/WO2021016148A1/en unknown
- 2020-07-20 EP EP20843735.0A patent/EP3998937A4/en active Pending
- 2020-07-20 MX MX2022000717A patent/MX2022000717A/es unknown
- 2020-07-20 KR KR1020227005255A patent/KR20220047280A/ko unknown
- 2020-07-20 CA CA3144397A patent/CA3144397A1/en active Pending
- 2020-07-20 JP JP2022502866A patent/JP7470453B2/ja active Active
- 2020-10-15 US US17/071,625 patent/US11778987B2/en active Active
-
2022
- 2022-01-17 IL IL289913A patent/IL289913A/en unknown
-
2023
- 2023-07-11 US US18/220,480 patent/US20230354779A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170202185A1 (en) | 2016-01-18 | 2017-07-20 | Dinklage Feed Yards, Inc. | Unmanned livestock monitoring system and methods of use |
Also Published As
Publication number | Publication date |
---|---|
US20210015079A1 (en) | 2021-01-21 |
US10980218B2 (en) | 2021-04-20 |
JP2022541505A (ja) | 2022-09-26 |
BR112022001051A2 (pt) | 2022-03-15 |
AU2020315882A1 (en) | 2022-02-10 |
MX2022000717A (es) | 2022-02-24 |
WO2021016148A1 (en) | 2021-01-28 |
US11778987B2 (en) | 2023-10-10 |
CN114828736A (zh) | 2022-07-29 |
EP3998937A4 (en) | 2023-08-16 |
US20230354779A1 (en) | 2023-11-09 |
US20210022321A1 (en) | 2021-01-28 |
EP3998937A1 (en) | 2022-05-25 |
IL289913A (en) | 2022-03-01 |
KR20220047280A (ko) | 2022-04-15 |
CA3144397A1 (en) | 2021-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7470453B2 (ja) | 動物データを監視用に収集および配信するための、無人航空機(uav)ベースのシステム | |
US20230131370A1 (en) | An unmanned aerial vehicle (uav)-based system for collecting and distributing animal data for monitoring | |
EP4299148A2 (en) | System for generating simulated animal data and models | |
US20210225505A1 (en) | Biological data tracking system and method | |
KR20220007063A (ko) | 동물 데이터 예측 시스템 | |
US20110246123A1 (en) | Personal status monitoring | |
JP7542861B2 (ja) | 生物学的データ追跡システムおよび方法 | |
Grigorescu et al. | Robotic platform with medical applications in the smart city environment | |
US20200102074A1 (en) | A device, method and system for an unmanned aerial vehicle health care companion | |
Ohno et al. | Cyber-enhanced rescue canine | |
JPWO2021016148A5 (ja) | ||
Elia et al. | A real‐world data collection framework for a fused dataset creation for joint human and remotely operated vehicle monitoring and anomalous command detection | |
US20230227183A1 (en) | Care Delivery Telehealth Drone | |
Shenoy | Sensor information processing for wearable iot devices | |
Chatzitofis et al. | Technological module for unsupervised, personalized cardiac rehabilitation exercising | |
US20220395237A1 (en) | Automatic ambulatory subject monitoring | |
WO2022261673A1 (en) | Automatic ambulatory non-human subject monitoring | |
Ibrahim et al. | Learning to Self-Manage by Intelligent Monitoring, Prediction and Intervention | |
COOPER et al. | Learning to self-manage by intelligent monitoring, prediction and intervention. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230719 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230719 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230721 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20230721 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230905 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231204 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240214 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240305 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240401 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7470453 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |